If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCohort Regulatory News (CHRT)

Share Price Information for Cohort (CHRT)

Share Price is delayed by 15 minutes
Get Live Data
1,422.00    -2.00 (-0.14%)
Bid:
1,432.00
Ask:
1,440.00
Spread: 8.00 (0.559%)
Market Cap: £651.71m
CHRT Live PriceLast checked at - London Stock Exchange

Intraday Cohort Share Chart

Director/PDMR Shareholding

14 Aug 2014 09:30

RNS Number : 1263P
Cohort PLC
14 August 2014
 



14 August 2014

COHORT PLC (the "Company")

Director Shareholdings, Share Awards and Options

Cohort plc (the "Company") wishes to notify the following changes in the interests of directors of the Company in ordinary shares of 10 pence in relation to share awards and share options.

Director shareholdings

Yesterday, the Company was notified that the sale of shares to satisfy share option exercise costs took place on 12 August 2014 as follows:

Description

Ordinary Shares

Market Value(pence)

Sale by AS Thomis' wife

25,477

197.25 p

Sale by SR Walther

7,644

197.25 p

Sale by SR Walther's wife

7,643

197.25 p

Following all transactions to date, including those detailed below, and subject to the completion of ISA transfers announced on 5 August 2014, Mr Thomis' and Mr Walther's interests and that of their connected persons are as follows:

Director

Ordinary shares

% of the total issued share capital

AS Thomis

86,225

0.21

SR Walther

78,892

0.19

Grant of Share Awards

On 11 August 2014 share awards pursuant to the 2013 Restricted Share Scheme established on 30 July 2013 ("Restricted Share Scheme") were granted to directors of the Company for nil consideration as follows:

Director

Number of sharesunder this award

Total number of unvested shares under the Restricted Share Scheme following grant

AS Thomis

19,342

20,556

SR Walther

15,595

17,196

Full beneficial ownership of Restricted Shares (including voting and dividend rights) will transfer to the recipients in stages over a three-year period from the date of grant. Recipients may only sell Restricted Shares with the approval of the Chairman of the Remuneration & Appointments Committee while they remain in employment with the Company. Further details regarding the Restricted Shares can be found in the Company's Annual Report and Accounts 2014.

Grant of Share Options

On 11 August 2014 share options pursuant to the Cohort plc 2006 Share Option Scheme ("Unapproved") and the Approved Share Option Subplan ("Approved") were granted to directors of the Company as follows:

Director

Number of shares under this option

Exercise Price(pence)

Total number of shares under option following grant

AS Thomis - Unapproved

4,153

197.5

246,944

Approved

15,189

197.5

15,189

SR Walther - Unapproved

406

197.5

172,580

Approved

15,189

197.5

15,189

The options can be exercised between 12 August 2017 and 11 August 2024.

On 11 August 2014 share options pursuant to the Cohort plc Savings Related Share Option Scheme ("SAYE Scheme") were granted to directors of the Company as follows:

Director

Number of shares underthis option

Exercise Price (pence)

Total number of shares under the SAYE Scheme following grant

AS Thomis

2,602

207.5

4,932

SR Walther

867

207.5

6,692

The options are made pursuant to three year savings contracts.

The total share options held under each scheme following grant as set out above includes the recent exercise of share options announced on 5 August 2014.

Ends

For further information, please contact

Cohort plc

Andrew Thomis, Chief ExecutiveSimon Walther, Finance Director

+44 (0)118 909 0390

Investec

Keith Anderson, Daniel Adams

+44 (0)20 7597 5970

MHP Communications

Reg Hoare, Vicky Watkins

+44 (0)20 3128 8100

Cohort plc

Cohort is an independent technology group working primarily for defence (air, land and sea), wider government and industry clients, through four market-facing subsidiary companies:

MASS - a specialist systems house with considerable experience in the defence market and a focus on electronic warfare operational support and secure information systems. Based in Cambridgeshire, MASS was acquired by Cohort in August 2006;

MCL - an expert in electronic and surveillance technology design and manufacturing, product and in the field support and training for a range of specialist UK end users, including the MOD and other governmental agencies. Based in Surrey, MCL has been part of the Group since July 2014;

SCS - a defence technical advisory business, combining technical expertise with practical experience and domain knowledge. Owned by Cohort since flotation in March 2006;

SEA - an advanced surveillance systems and software house with hardware development capability operating in the defence and transport market sectors. Acquired by Cohort in October 2007.

Cohort was admitted to London's Alternative Investment Market in March 2006. It has its headquarters in Berkshire and employs in total around 500 core staff there and at its other operating company sites in Bristol, Cambridgeshire, Lincolnshire, Somerset and Surrey.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSGIGDIGXBBGSS
Date   Source Headline
20th Sep 202410:48 amRNSDirector/PDMR Shareholding
16th Sep 20245:34 pmRNSHolding(s) in Company
2nd Sep 20245:08 pmRNSTotal Voting Rights
2nd Sep 202411:32 amRNSHolding(s) in Company
27th Aug 20245:54 pmRNSBlock listing six monthly return
21st Aug 20247:00 amRNSAnnual Report and Notice of Annual General Meeting
19th Aug 20243:48 pmRNSDirector/PDMR Shareholding
16th Aug 202412:10 pmRNSHolding(s) in Company
12th Aug 20244:22 pmRNSDirector/PDMR Shareholding
2nd Aug 20242:30 pmRNSDirector/PDMR Shareholding
1st Aug 202411:43 amRNSTotal Voting Rights
29th Jul 20249:45 amRNSDirector/PDMR Shareholding
23rd Jul 20245:04 pmRNSDirector/PDMR Shareholding
17th Jul 20247:01 amRNSContract win
17th Jul 20247:00 amRNSFinal Results
15th Jul 20247:00 amRNSContract Award
11th Jul 20247:00 amRNSNotice of Results
1st Jul 20249:33 amRNSTotal Voting Rights
5th Jun 202410:59 amRNSEBT Purchase of Shares
31st May 20243:17 pmRNSTotal Voting Rights
23rd May 20241:30 pmRNSEBT Purchase of Shares
23rd May 20247:00 amRNSFull Year Trading Update
20th May 20244:01 pmRNSEBT Purchase of Shares
14th May 20242:10 pmRNSEBT Purchase of Shares
7th May 20245:24 pmRNSEBT Purchase of Shares
3rd May 202411:44 amRNSDirector/PDMR Shareholding
1st May 20245:17 pmRNSDirector/PDMR Shareholding
1st May 20245:11 pmRNSTotal Voting Rights
30th Apr 20247:00 amRNSBlock Listing Application
30th Apr 20247:00 amRNSSite visit to SEA
15th Apr 20247:00 amRNSDirector/PDMR Shareholding
8th Apr 20242:19 pmRNSDirector/PDMR Shareholding
2nd Apr 20243:19 pmRNSBlock Listing Six Monthly Return
2nd Apr 20243:17 pmRNSTotal Voting Rights
28th Mar 20242:06 pmRNSHolding(s) in Company
27th Mar 20244:00 pmRNSDirector/PDMR Shareholding
26th Mar 20247:00 amRNSContract Win
19th Mar 20249:43 amRNSContract win
13th Mar 202410:49 amRNSDirector/PDMR Shareholding
1st Mar 20247:00 amRNSTotal Voting Rights
26th Feb 20244:28 pmRNSBlock listing six monthly return
16th Feb 202412:38 pmRNSDirector/PDMR Shareholding
1st Feb 202410:02 amRNSTotal Voting Rights
29th Jan 20247:00 amRNSContract Win
17th Jan 20243:25 pmRNSDirector/PDMR Shareholding
15th Jan 20247:00 amRNSInterim Report 2023
2nd Jan 202412:05 pmRNSTotal Voting Rights
22nd Dec 202312:07 pmRNSHolding(s) in Company
13th Dec 20237:01 amRNSDirectorate Change
13th Dec 20237:00 amRNSHalf Year Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.